tTG is overexpressed in many of the most aggressive cancers [2], and tTG knockout mice are predominantly healthy, with their phenotypes being variously reported as normal [104], or only slightly disrupted [105], and so tTG inhibitors would be expected to be minimally toxic. The gene discussed is TGM2; the disease is cancer.